REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27,223 | +2622.3% | 267 | +2327.3% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 11 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 11 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -85.7% | 11 | -76.1% | 0.00% | – |
| Q2 2020 | $7,000 | 0.0% | 46 | -8.0% | 0.00% | -100.0% |
| Q1 2020 | $7,000 | -96.4% | 50 | -94.7% | 0.00% | -91.7% |
| Q4 2019 | $193,000 | +467.6% | 940 | +161.1% | 0.01% | +500.0% |
| Q2 2019 | $34,000 | -50.7% | 360 | -55.0% | 0.00% | -60.0% |
| Q1 2019 | $69,000 | -15.9% | 800 | -45.5% | 0.01% | -28.6% |
| Q4 2018 | $82,000 | +9.3% | 1,469 | +60.9% | 0.01% | +16.7% |
| Q3 2018 | $75,000 | +3650.0% | 913 | +1622.6% | 0.01% | – |
| Q4 2017 | $2,000 | 0.0% | 53 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 53 | +76.7% | 0.00% | – |
| Q1 2017 | $1,000 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |